Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

TELA Bio Q3 2023 EPS $(0.45) Beats $(0.49) Estimate, Sales $15.05M Miss $16.20M Estimate

Author: Benzinga Newsdesk | November 09, 2023 05:25pm
TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.49) by 8.16 percent. This is a 29.69 percent increase over losses of $(0.64) per share from the same period last year. The company reported quarterly sales of $15.05 million which missed the analyst consensus estimate of $16.20 million by 7.09 percent. This is a 34.89 percent increase over sales of $11.16 million the same period last year.

Posted In: TELA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist